Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00134251
Status:
COMPLETED
Last Update Posted:
2009-01-30
First Post:
2005-08-22
Brief Title:
Ascending Dose TolerabilitySafety of SLV308 for the Treatment of Parkinsons Disease
Sponsor:
Solvay Pharmaceuticals
Organization:
Solvay Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-10
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2005-08-22
First Submit QC Date:
August 22 2005
Study First Post Date:
2005-08-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-01-29
Last Update Post Date:
2009-01-30
Last Update Post Date Type:
ESTIMATED